knowledge -WSS

knowledge

author：entertainment 2025-09-06 01:23:29 - browse：42

Janet Woodcock -- health policy coverage from STAT — Janet Woodcock, the FDA's principal deputy commissioner Chip Somodevilla/Getty Images

WASHINGTON — It’s the end of an era for the Food and Drug Administration’s longtime drug chief, but she’s drawn the battle plans for the agency’s next chapter.

Janet Woodcock joined the FDA’s biologics division in 1986 but soon moved to the drug side, where over nearly three decades, she oversaw hundreds of reviews, new and evolving classes of therapies and several clashes with Congress and patient advocates. In recent years, she also warded off attacks on the agency’s decisionmaking during the Covid-19 pandemic, particularly when the agency veteran took the acting commissioner role during President Biden’s long search for a permanent leader, and took charge of a vast reorganization plan sparked by the baby formula crisis.

Some of those efforts still hang in the balance as she departs this week. Critics argue that under her oversight, the drug division worked too closely with pharmaceutical companies to give broad approvals to new medicines like Biogen’s Aduhelm or so-called accelerated approval to controversial therapies like Sarepta’s Duchenne muscular dystrophy medicine Exondys 51, which is still in the midst of post-marketing studies to prove its effectiveness.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Removing probiotics from the NICU could threaten preemies' health

explore

WSS

The new shift in health care is toward less care

Study: New antibiotic targets gonorrhea as well as last existing drug

'Cuddling' is just what the doctor ordered for a 200

Victims of gun violence feel impacts long after bullet wound

Climate activists disrupt London Pride march to protest corporate sponsorship

Eat, drink, but be wary — 4 foods that interact with medications

Wikipedia

knowledge

leisure time

Moonlake's readout produced a cash windfall. Risks remain

Pediatricians' group reaffirms support for gender

Jerome Adams on the need for new antivirals for Covid

Eat, drink, but be wary — 4 foods that interact with medications

Apple is now the first public company to be valued at $3 trillion

White House calls on federal agencies to crack down on AI abuses

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The new shift in health care is toward less care

The high cost of giving birth even with insurance

Scientists find bacteria from stomach of ancient iceman

explore

Diversify hospital leadership teams to protect BIPOC patient health

Study: New antibiotic targets gonorrhea as well as last existing drug

Prosecutors seek bail revocation for FTX founder Sam Bankman

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

HPV cancer vaccine study demonstrates efficacy

explore

explore

leisure time

entertainment